Nanocarriers for biomedicine: From lipid formulations to inorganic and hybrid nanoparticles

R Kashapov, A Ibragimova, R Pavlov… - International Journal of …, 2021 - mdpi.com
Encapsulation of cargoes in nanocontainers is widely used in different fields to solve the
problems of their solubility, homogeneity, stability, protection from unwanted chemical and …

Gastrointestinal permeation enhancers for the development of oral peptide pharmaceuticals

JC Kim, EJ Park, DH Na - Pharmaceuticals, 2022 - mdpi.com
Recently, two oral-administered peptide pharmaceuticals, semaglutide and octreotide, have
been developed and are considered as a breakthrough in peptide and protein drug delivery …

Linolenic acid conjugated chitosan micelles for improving the oral absorption of doxorubicin via fatty acid transporter

Y Yang, Y Chen, D Li, S Lin, H Chen, W Wu… - Carbohydrate …, 2023 - Elsevier
A novel delivery system based on linolenic acid (LA) conjugated chitosan (CS) polymeric
micelles were proposed for improving the oral absorption of doxorubicin (DOX) through …

Use of novel taurine-chitosan mediated liposomes for enhancing the oral absorption of doxorubicin via the TAUT transporter

S Qin, Z Wen, H Huang, W Wu - Carbohydrate Polymers, 2024 - Elsevier
Our research aimed to enhance the oral bioavailability of doxorubicin hydrochloride (DOX·
HCl) while minimizing the potential for myocardial toxicity. To achieve this goal, we …

Gastrointestinally absorbable lactoferrin-heparin conjugate with anti-angiogenic activity for treatment of brain tumor

HH Hwang, HS Kim, DY Lee - Journal of Controlled Release, 2023 - Elsevier
Glioblastoma multiforme (GBM) is a central nervous system disease with poor prognosis.
Curative treatments for GBM involve chemotherapy, radiotherapy, and surgical pathways …

Peptide permeation enhancers for improving oral bioavailability of macromolecules

D Kim, L Jin, EJ Park, DH Na - Journal of Pharmaceutical Investigation, 2023 - Springer
Background Oral delivery of macromolecules has been limited mainly by their low intestinal
permeability. Chemical permeation enhancers (CPEs) are typically used to improve …

Design of chimeric GLP-1A using oligomeric bile acids to utilize transporter-mediated endocytosis for oral delivery

S Kweon, JH Lee, SB Yang, SJ Park, L Subedi… - Biomaterials …, 2023 - spj.science.org
Background Despite the effectiveness of glucagon-like peptide-1 agonist (GLP-1A) in the
treatment of diabetes, its large molecular weight and high hydrophilicity result in poor …

Measurement and correlation of solubility of rivaroxaban in dichloromethane and primary alcohol binary solvent mixtures at different temperatures

JS Jeong, ES Ha, H Park, SK Lee, JS Kim… - Journal of Molecular …, 2022 - Elsevier
The solubility of rivaroxaban in different solvent mixtures consisting of dichloromethane and
primary alcohols, including methanol, ethanol, n-propanol, and n-butanol, was evaluated …

Advancements in 5-Fluorouracil-Loaded Liposomal Nanosystems: A Comprehensive Review on Recent Innovations in Nanomedicine for Cancer Therapy

MS Ali, SK Jha, G Gupta, A Alsayari, S Wahab… - Journal of Drug Delivery …, 2024 - Elsevier
The increasing worldwide cancer prevalence is a result of population aging and expansion
and changes in individuals' exposure to risk factors, many of which are linked to …

Enhancement of the anticancer effect of atorvastatin-loaded nanoemulsions by improving oral absorption via multivalent intestinal transporter-targeting lipids

L Subedi, P Pandey, B Khadka, JH Shim, SS Cho… - Drug Delivery, 2022 - Taylor & Francis
Atorvastatin (ATV) has attracted considerable attention as a potential therapeutic agent for
cancer because it inhibits cancer cell proliferation by suppressing the mevalonate pathway …